English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 6 December 2019, 19:16 JST
Share:
    

Source: Hitachi, Ltd.
Hitachi to Provide CNAO with Proton Therapy System

TOKYO, Dec 6, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.

Centro Nazionale di Adroterapia Oncologica (National Center for Oncological Hadrontherapy for the treatment of tumors)

In the comprehensive public tender process, Hitachi has been selected to provide proton therapy systems with the latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.

The agreement includes multiyear service and maintenance of the system and this will be the 1st Hitachi Proton Therapy System to be installed in Italy and the 2nd in Europe.

CNAO, located in Pavia (near Milan), Italy, is a world's leading clinical center on particle cancer therapy and the first national hadrontherapy center in Italy. CNAO was established and is operated by the CNAO Foundation, a non-profit organization fully funded by the Italian government. CNAO has started cancer treatment for proton therapy since 2011 and heavy ion therapy since 2012, and it will develop a new proton therapy facility to enhance further research and cancer treatment.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will contribute to the improvement of people's quality of life and social values through the global expansion of its particle therapy system business.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products. The company's consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 9,480.6 billion yen ($85.4 billion), and the company has approximately 296,000 employees worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase our customer's social, environmental and economic value. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

Topic: Press release summary
Source: Hitachi, Ltd.

Sectors: BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 
Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd. Related News
Thursday, 6 February 2025, 16:32 JST
Hitachi establishes its fourth Corporate Venture Capital Fund to capture technology turning points and future growth opportunities
Friday, 24 January 2025, 12:40 JST
Hitachi Launches Food Quality Visualization Solution with Time-Temperature Sensing Ink
Monday, 20 January 2025, 15:07 JST
Hitachi Acquires a Sales and Maintenance Service Company for Large Motors in the United States
Tuesday, 24 December 2024, 13:19 JST
Hitachi delivers a turnkey rail solution for Ho Chi Minh City's first urban railway Line 1 in Vietnam
Tuesday, 10 December 2024, 19:16 JST
Provision of the First Template Function Adapted to the IFRS Sustainability Disclosure Standards in Japan (IFRS S1 and S2) on the Sustainable Finance Platform
More news >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575